WELL Health Technologies Corp.

WELL.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WELL.TO stands at 996.3M. In comparison, EXE.TO has a market cap of 2.6B. Regarding current trading prices, WELL.TO is priced at CA$3.90, while EXE.TO trades at CA$27.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WELL.TO currently has a P/E ratio of -130.00, whereas EXE.TO's P/E ratio is 25.01. In terms of profitability, WELL.TO's ROE is -0.01%, compared to EXE.TO's ROE of +0.48%. Regarding short-term risk, WELL.TO is more volatile compared to EXE.TO. This indicates potentially higher risk in terms of short-term price fluctuations for WELL.TO.Check EXE.TO's competition here

WELL.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WELL.TO stands at 996.3M. In comparison, SIA.TO has a market cap of 2.2B. Regarding current trading prices, WELL.TO is priced at CA$3.90, while SIA.TO trades at CA$22.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WELL.TO currently has a P/E ratio of -130.00, whereas SIA.TO's P/E ratio is 45.73. In terms of profitability, WELL.TO's ROE is -0.01%, compared to SIA.TO's ROE of +0.07%. Regarding short-term risk, WELL.TO is more volatile compared to SIA.TO. This indicates potentially higher risk in terms of short-term price fluctuations for WELL.TO.Check SIA.TO's competition here

WELL.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WELL.TO stands at 996.3M. In comparison, DNTL.TO has a market cap of 2.1B. Regarding current trading prices, WELL.TO is priced at CA$3.90, while DNTL.TO trades at CA$11.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WELL.TO currently has a P/E ratio of -130.00, whereas DNTL.TO's P/E ratio is -78.57. In terms of profitability, WELL.TO's ROE is -0.01%, compared to DNTL.TO's ROE of -0.02%. Regarding short-term risk, WELL.TO is more volatile compared to DNTL.TO. This indicates potentially higher risk in terms of short-term price fluctuations for WELL.TO.Check DNTL.TO's competition here

WELL.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WELL.TO stands at 996.3M. In comparison, DR.TO has a market cap of 298.2M. Regarding current trading prices, WELL.TO is priced at CA$3.90, while DR.TO trades at CA$16.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WELL.TO currently has a P/E ratio of -130.00, whereas DR.TO's P/E ratio is 15.02. In terms of profitability, WELL.TO's ROE is -0.01%, compared to DR.TO's ROE of +0.28%. Regarding short-term risk, WELL.TO is more volatile compared to DR.TO. This indicates potentially higher risk in terms of short-term price fluctuations for WELL.TO.Check DR.TO's competition here

WELL.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WELL.TO stands at 996.3M. In comparison, AIDX.TO has a market cap of 237.6M. Regarding current trading prices, WELL.TO is priced at CA$3.90, while AIDX.TO trades at CA$0.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WELL.TO currently has a P/E ratio of -130.00, whereas AIDX.TO's P/E ratio is -5.40. In terms of profitability, WELL.TO's ROE is -0.01%, compared to AIDX.TO's ROE of -0.39%. Regarding short-term risk, WELL.TO is less volatile compared to AIDX.TO. This indicates potentially lower risk in terms of short-term price fluctuations for WELL.TO.Check AIDX.TO's competition here

WELL.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WELL.TO stands at 996.3M. In comparison, CRRX.TO has a market cap of 221.4M. Regarding current trading prices, WELL.TO is priced at CA$3.90, while CRRX.TO trades at CA$3.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WELL.TO currently has a P/E ratio of -130.00, whereas CRRX.TO's P/E ratio is 8.61. In terms of profitability, WELL.TO's ROE is -0.01%, compared to CRRX.TO's ROE of +0.28%. Regarding short-term risk, WELL.TO is more volatile compared to CRRX.TO. This indicates potentially higher risk in terms of short-term price fluctuations for WELL.TO.Check CRRX.TO's competition here

WELL.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WELL.TO stands at 996.3M. In comparison, DRDR.TO has a market cap of 49.4M. Regarding current trading prices, WELL.TO is priced at CA$3.90, while DRDR.TO trades at CA$0.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WELL.TO currently has a P/E ratio of -130.00, whereas DRDR.TO's P/E ratio is -0.83. In terms of profitability, WELL.TO's ROE is -0.01%, compared to DRDR.TO's ROE of -1.02%. Regarding short-term risk, WELL.TO is less volatile compared to DRDR.TO. This indicates potentially lower risk in terms of short-term price fluctuations for WELL.TO.Check DRDR.TO's competition here

WELL.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WELL.TO stands at 996.3M. In comparison, GTMS.TO has a market cap of 28.6M. Regarding current trading prices, WELL.TO is priced at CA$3.90, while GTMS.TO trades at CA$0.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WELL.TO currently has a P/E ratio of -130.00, whereas GTMS.TO's P/E ratio is -0.45. In terms of profitability, WELL.TO's ROE is -0.01%, compared to GTMS.TO's ROE of +15.74%. Regarding short-term risk, WELL.TO is less volatile compared to GTMS.TO. This indicates potentially lower risk in terms of short-term price fluctuations for WELL.TO.Check GTMS.TO's competition here

WELL.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WELL.TO stands at 996.3M. In comparison, NUMI.TO has a market cap of 16M. Regarding current trading prices, WELL.TO is priced at CA$3.90, while NUMI.TO trades at CA$0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WELL.TO currently has a P/E ratio of -130.00, whereas NUMI.TO's P/E ratio is -0.63. In terms of profitability, WELL.TO's ROE is -0.01%, compared to NUMI.TO's ROE of +11.51%. Regarding short-term risk, WELL.TO is more volatile compared to NUMI.TO. This indicates potentially higher risk in terms of short-term price fluctuations for WELL.TO.Check NUMI.TO's competition here

WELL.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WELL.TO stands at 996.3M. In comparison, EPW.CN has a market cap of 4.1M. Regarding current trading prices, WELL.TO is priced at CA$3.90, while EPW.CN trades at CA$0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WELL.TO currently has a P/E ratio of -130.00, whereas EPW.CN's P/E ratio is -0.27. In terms of profitability, WELL.TO's ROE is -0.01%, compared to EPW.CN's ROE of +0.47%. Regarding short-term risk, WELL.TO is more volatile compared to EPW.CN. This indicates potentially higher risk in terms of short-term price fluctuations for WELL.TO.Check EPW.CN's competition here

WELL.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WELL.TO stands at 996.3M. In comparison, CALM.CN has a market cap of 2.8M. Regarding current trading prices, WELL.TO is priced at CA$3.90, while CALM.CN trades at CA$0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WELL.TO currently has a P/E ratio of -130.00, whereas CALM.CN's P/E ratio is -0.11. In terms of profitability, WELL.TO's ROE is -0.01%, compared to CALM.CN's ROE of +3.14%. Regarding short-term risk, WELL.TO is more volatile compared to CALM.CN. This indicates potentially higher risk in terms of short-term price fluctuations for WELL.TO.Check CALM.CN's competition here

WELL.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WELL.TO stands at 996.3M. In comparison, OMIC.CN has a market cap of 2.3M. Regarding current trading prices, WELL.TO is priced at CA$3.90, while OMIC.CN trades at CA$0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WELL.TO currently has a P/E ratio of -130.00, whereas OMIC.CN's P/E ratio is -4.50. In terms of profitability, WELL.TO's ROE is -0.01%, compared to OMIC.CN's ROE of -0.83%. Regarding short-term risk, WELL.TO is more volatile compared to OMIC.CN. This indicates potentially higher risk in terms of short-term price fluctuations for WELL.TO.Check OMIC.CN's competition here

WELL.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WELL.TO stands at 996.3M. In comparison, MEDI.NE has a market cap of 17.8K. Regarding current trading prices, WELL.TO is priced at CA$3.90, while MEDI.NE trades at CA$0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WELL.TO currently has a P/E ratio of -130.00, whereas MEDI.NE's P/E ratio is -0.02. In terms of profitability, WELL.TO's ROE is -0.01%, compared to MEDI.NE's ROE of N/A. Regarding short-term risk, WELL.TO is less volatile compared to MEDI.NE. This indicates potentially lower risk in terms of short-term price fluctuations for WELL.TO.Check MEDI.NE's competition here